• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于评估心力衰竭治疗中综合护理和经济结果的新型混合建模方法。

A novel hybrid modeling approach for the evaluation of integrated care and economic outcome in heart failure treatment.

机构信息

Institute of Health Care Engineering, Graz University of Technology, Stremayrgasse 16/II, 8010, Graz, Austria.

Steiermärkische Krankenanstaltengesellschaft m.b.H. (KAGes), Stiftingtalstraße 4-6, 8010, Graz, Austria.

出版信息

BMC Med Inform Decis Mak. 2019 Nov 21;19(1):229. doi: 10.1186/s12911-019-0944-3.

DOI:10.1186/s12911-019-0944-3
PMID:31752819
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6868721/
Abstract

BACKGROUND

Demographic changes, increased life expectancy and the associated rise in chronic diseases pose challenges to public health care systems. Optimized treatment methods and integrated concepts of care are potential solutions to overcome increasing financial burdens and improve quality of care. In this context modeling is a powerful tool to evaluate potential benefits of different treatment procedures on health outcomes as well as health care budgets. This work presents a novel modeling approach for simulating different treatment procedures of heart failure patients based on extensive data sets from outpatient and inpatient care.

METHODS

Our hybrid heart failure model is based on discrete event and agent based methodologies and facilitates the incorporation of different therapeutic procedures for outpatient and inpatient care on patient individual level. The state of health is modeled with the functional classification of the New York Heart Association (NYHA), strongly affecting discrete state transition probabilities alongside age and gender. Cooperation with Austrian health care and health insurance providers allowed the realization of a detailed model structure based on clinical data of more than 25,000 patients.

RESULTS

Simulation results of conventional care and a telemonitoring program underline the unfavorable prognosis for heart failure and reveal the correlation of NYHA classes with health and economic outcomes. Average expenses for the treatment of NYHA class IV patients of €10,077 ± €165 were more than doubled compared to other classes. The selected use case of a telemonitoring program demonstrated potential cost savings within two years of application. NYHA classes II and III revealed most potential for additional treatment measures.

CONCLUSION

The presented model allows performing extensive simulations of established treatment procedures for heart failure patients and evaluating new holistic methods of care and innovative study designs. This approach offers health care providers a unique, adaptable and comprehensive tool for decision making in the complex and socioeconomically challenging field of cardiovascular diseases.

摘要

背景

人口结构变化、预期寿命延长以及由此导致的慢性疾病增加,给公共医疗保健系统带来了挑战。优化的治疗方法和综合护理理念是克服不断增加的财务负担和提高护理质量的潜在解决方案。在这种情况下,建模是评估不同治疗方法对健康结果和医疗保健预算潜在影响的有力工具。本研究提出了一种新的建模方法,用于模拟心力衰竭患者的不同治疗方法,该方法基于门诊和住院护理的广泛数据集。

方法

我们的混合心力衰竭模型基于离散事件和基于代理的方法,能够在患者个体层面上纳入门诊和住院治疗的不同治疗程序。健康状况采用纽约心脏协会(NYHA)的功能分类进行建模,强烈影响离散状态转移概率,同时还受年龄和性别影响。与奥地利医疗保健和医疗保险提供商的合作使得能够根据超过 25000 名患者的临床数据实现详细的模型结构。

结果

常规护理和远程监测计划的模拟结果突显了心力衰竭的不利预后,并揭示了 NYHA 分级与健康和经济结果之间的相关性。与其他分级相比,NYHA 分级 IV 患者的治疗费用平均为 10077 欧元±165 欧元,增加了一倍多。选择远程监测计划的用例表明,在应用两年内可能会节省成本。NYHA 分级 II 和 III 显示出对额外治疗措施的最大潜力。

结论

所提出的模型允许对心力衰竭患者的既定治疗程序进行广泛模拟,并评估新的整体护理方法和创新的研究设计。这种方法为医疗保健提供者提供了一个独特、适应性强且全面的决策工具,用于处理心血管疾病这一复杂且具有社会经济挑战性的领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/ed5096ee8d51/12911_2019_944_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/dac42ef7fdb2/12911_2019_944_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/033b303f5ba6/12911_2019_944_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/df2fdded0250/12911_2019_944_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/08b0da878346/12911_2019_944_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/68fbe9c3de92/12911_2019_944_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/c300209802b8/12911_2019_944_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/e7b5cc0749d9/12911_2019_944_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/844e3e6d2528/12911_2019_944_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/7d59c5ba909b/12911_2019_944_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/9c4f4456581c/12911_2019_944_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/96a5bcdda037/12911_2019_944_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/ed5096ee8d51/12911_2019_944_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/dac42ef7fdb2/12911_2019_944_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/033b303f5ba6/12911_2019_944_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/df2fdded0250/12911_2019_944_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/08b0da878346/12911_2019_944_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/68fbe9c3de92/12911_2019_944_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/c300209802b8/12911_2019_944_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/e7b5cc0749d9/12911_2019_944_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/844e3e6d2528/12911_2019_944_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/7d59c5ba909b/12911_2019_944_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/9c4f4456581c/12911_2019_944_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/96a5bcdda037/12911_2019_944_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a70/6868721/ed5096ee8d51/12911_2019_944_Fig12_HTML.jpg

相似文献

1
A novel hybrid modeling approach for the evaluation of integrated care and economic outcome in heart failure treatment.一种用于评估心力衰竭治疗中综合护理和经济结果的新型混合建模方法。
BMC Med Inform Decis Mak. 2019 Nov 21;19(1):229. doi: 10.1186/s12911-019-0944-3.
2
Simulation model for cost estimation of integrated care concepts of heart failure patients.用于心力衰竭患者综合护理概念成本估算的仿真模型。
Health Econ Rev. 2013 Nov 12;3(1):26. doi: 10.1186/2191-1991-3-26.
3
The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.心脏再同步治疗(双心室起搏)用于心力衰竭的临床疗效及成本效益:系统评价与经济学模型
Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. doi: 10.3310/hta11470.
4
First outline and baseline data of a randomized, controlled multicenter trial to evaluate the health economic impact of home telemonitoring in chronic heart failure - CardioBBEAT.一项评估家庭远程监测对慢性心力衰竭健康经济影响的随机对照多中心试验——CardioBBEAT的初步概述和基线数据。
Trials. 2015 Aug 11;16:343. doi: 10.1186/s13063-015-0886-8.
5
Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.慢性心力衰竭的成本/效用比:日间医院提供的心力衰竭管理项目与常规护理的比较。
J Am Coll Cardiol. 2002 Oct 2;40(7):1259-66. doi: 10.1016/s0735-1097(02)02140-x.
6
Cost-Effectiveness Analysis in Telehealth: A Comparison between Home Telemonitoring, Nurse Telephone Support, and Usual Care in Chronic Heart Failure Management.远程医疗中的成本效益分析:家庭远程监测、护士电话支持与慢性心力衰竭管理中常规护理的比较。
Value Health. 2018 Jul;21(7):772-782. doi: 10.1016/j.jval.2017.11.011. Epub 2018 Mar 21.
7
Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure.在一个大型、随机、基于社区的心力衰竭人群中,疾病管理的长期医疗保健和成本结果。
Circulation. 2004 Dec 7;110(23):3518-26. doi: 10.1161/01.CIR.0000148957.62328.89. Epub 2004 Nov 7.
8
Value of information analysis in telehealth for chronic heart failure management.信息价值分析在远程医疗慢性心力衰竭管理中的应用。
PLoS One. 2019 Jun 20;14(6):e0218083. doi: 10.1371/journal.pone.0218083. eCollection 2019.
9
[Does telemonitoring lead to health and economic benefits in patients with chronic heart failure? - a systematic review].[远程监测对慢性心力衰竭患者是否带来健康和经济效益?- 一项系统综述]
Gesundheitswesen. 2012 Dec;74(12):e114-21. doi: 10.1055/s-0032-1309021. Epub 2012 May 21.
10
An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany.德国晚期慢性心力衰竭患者压力反射激活疗法的成本效用早期分析。
BMC Cardiovasc Disord. 2018 Aug 9;18(1):163. doi: 10.1186/s12872-018-0898-x.

引用本文的文献

1
Forecasting cardiovascular disease risk and burden in China from 2020 to 2030: a simulation study based on a nationwide cohort.预测2020年至2030年中国心血管疾病的风险和负担:一项基于全国队列的模拟研究
Heart. 2025 Feb 12;111(5):205-211. doi: 10.1136/heartjnl-2024-324650.
2
Assessing Patient Engagement in Health Care: Proposal for a Modeling and Simulation Framework for Behavioral Analysis.评估患者在医疗保健中的参与度:行为分析建模与仿真框架提案。
JMIR Res Protoc. 2021 Dec 8;10(12):e30092. doi: 10.2196/30092.

本文引用的文献

1
Care setting and 30-day hospital readmissions among older adults: a population-based cohort study.老年人的医疗环境和 30 天内的医院再入院率:一项基于人群的队列研究。
CMAJ. 2018 Sep 24;190(38):E1124-E1133. doi: 10.1503/cmaj.180290.
2
Systematic review of economic burden of heart failure.心力衰竭经济负担的系统评价。
Heart Fail Rev. 2018 Jan;23(1):131-145. doi: 10.1007/s10741-017-9661-0.
3
Multi-state modelling of heart failure care path: A population-based investigation from Italy.心力衰竭护理路径的多状态建模:来自意大利的一项基于人群的调查。
PLoS One. 2017 Jun 7;12(6):e0179176. doi: 10.1371/journal.pone.0179176. eCollection 2017.
4
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.慢性心力衰竭伴射血分数保留、中间范围和降低患者的流行病学和一年结局:ESC 心力衰竭长期注册研究分析。
Eur J Heart Fail. 2017 Dec;19(12):1574-1585. doi: 10.1002/ejhf.813. Epub 2017 Apr 6.
5
Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭住院患者的特征和结局的性别和种族差异。
J Am Heart Assoc. 2017 Mar 29;6(4):e003330. doi: 10.1161/JAHA.116.003330.
6
Does integrated care reduce hospital activity for patients with chronic diseases? An umbrella review of systematic reviews.综合护理能否减少慢性病患者的住院治疗?一项系统评价的伞状综述。
BMJ Open. 2016 Nov 21;6(11):e011952. doi: 10.1136/bmjopen-2016-011952.
7
Effectiveness and Factors Determining the Success of Management Programs for Patients With Heart Failure: A Systematic Review and Meta-analysis.心力衰竭患者管理项目的有效性及决定其成功的因素:一项系统评价与荟萃分析
Rev Esp Cardiol (Engl Ed). 2016 Oct;69(10):900-914. doi: 10.1016/j.rec.2016.05.012.
8
Statistical models for the analysis of skewed healthcare cost data: a simulation study.用于分析偏态医疗成本数据的统计模型:一项模拟研究。
Health Econ Rev. 2015 May 27;5:11. doi: 10.1186/s13561-015-0045-7. eCollection 2015.
9
A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010.2000年至2010年明尼苏达州奥尔姆斯特德县心力衰竭流行情况的当代评估。
JAMA Intern Med. 2015 Jun;175(6):996-1004. doi: 10.1001/jamainternmed.2015.0924.
10
Does intermediate care improve patient outcomes or reduce costs?中级护理能否改善患者预后或降低成本?
Crit Care. 2015 Mar 2;19(1):89. doi: 10.1186/s13054-015-0813-0.